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Nanoparticles of chitosan conjugated to organo-
ruthenium complexes†
Yanqing Wang,a,b Anaïs Pitto-Barry,b Abraha Habtemariam,b
Isolda Romero-Canelon,b Peter J. Sadler*b and Nicolas P. E. Barry*b
The synthesis of nanoparticles of conjugates of caﬀeic acid-modiﬁed chitosan with ruthenium arene
complexes is described. The chemical structure and physical properties of the nanoparticles were char-
acterised by electronic absorption spectroscopy (UV-vis), Fourier transform infrared spectroscopy (FT-IR),
1H NMR spectroscopy, dynamic light scattering (DLS), transmission electron microscopy (TEM), X-ray
powder diﬀraction (XRD), and circular dichroism (CD) analysis. The multi-spectral results revealed that
caﬀeic acid is covalently bound to chitosan and chelates to {Ru(p-cymene)Cl}+. The DLS studies indicated
that the Ru–caﬀeic acid modiﬁed chitosan nanoparticles are well-deﬁned and of nanometre size. Such
well-deﬁned nanocomposites of chitosan and metal complexes might ﬁnd a range of applications, for
example in drug delivery.
Introduction to the international collaboration
Yanqing Wang from Yancheng Teachers University, People’s Republic of China is developing a research programme in the exciting area of medicinal
inorganic chemistry, and in particular the design of nanoparticles for the delivery of metal anticancer complexes. He was awarded a research fellowship from
the Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and President to spend the year from February
2014 to February 2015 in the laboratory of Peter Sadler at the University of Warwick, UK. There he carried out research in bioinorganic chemistry on topics
related to the design and synthesis of nanoparticle conjugates of natural polymers with organo-ruthenium complexes. He synthesised nanocomposites of
caﬀeic acid-modified chitosan linked to ruthenium arene complexes. Chitosan is deacetylated chitin, found in the exoskeleton of crustaceans and cell walls
of fungi. Such well-defined nanocomposites of chitosan and metal complexes might find a range of applications, for example in drug delivery.
Introduction
Nanocarriers are constituted of sub-micron particles
(≤100 nm) with various morphologies such as nanocapsules,
polymer nanoparticles, liposomes, micelles.1 The innovation
in such systems lies in the fact that they eliminate a number of
impediments that hamper the action of conventional drugs.2
The solubility of poorly water soluble drugs may be controlled
by entrapping them into crystalline nano suspensions,3 or by
combination with organic or lipid nanoparticles to ensure
their circulation in blood for longer periods of time.4 Nano-
particles (NPs) made of polymers are of particular interest as
drug delivery systems, owing to their synthetic versatility, as
well as their tuneable properties (e.g. thermosensitivity and
pH-response).5–7 Examples of metallated NPs include micellar
metal-based MRI or SPECT/CT imaging agents,8,9 and formu-
lation NC-6004 or Nanoplatin™ (cisplatin encapsulated in
micelles composed of PEG and poly(γ-benzyl-L-glutamate)
(PEG-PGlu)), which is under phase I/II clinical evaluation for
the treatment of pancreatic cancer.10
The development of nanostructured materials functiona-
lised with metal complexes as alternatives for administering
anticancer metallodrugs is currently receiving attention with
synthetic polymers,11–20 however, little is known about the utili-
sation of natural polymers. Nanoparticles based on biopoly-
mers, such as the cationic polysaccharide chitosan, have been
demonstrated to possess various favourable features including
those for drug and gene delivery, biosensing, therapy, and
molecular imaging because of their excellent high biocompati-
bility, bio-degradation, hydrophilicity, and low toxicity toward
mammalian cells.21–24 The hydroxyl and amine groups located
on the backbone of chitosan allow simple chemical modifi-
cations (e.g. via Schiﬀ-bases and metal chelation), thus
enabling the design of libraries of multifunctional structures of
chitosan with potential for biological applications.25
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c6qi00115g
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University, Yancheng City, Jiangsu Province 224002, People’s Republic of China
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Here we report the synthesis of novel nano-construct
materials made up of ruthenium complexes with biocomp-
atible and biodegradable chitosan macro-ligands, thereby
opening the way to chitosan controlled metallodrug delivery.
Modifications of the NH2 functional group in the chitosan
matrix provide a platform for the introduction of the capability
to interact strongly with ruthenium(II) ions through com-
plex formation. Caﬀeic acid was selected to modify
chitosan because it is a natural product commonly found in
e.g. coﬀee, olive oil, white wine, and cabbage26 and acts as car-
cinogenic inhibitor and shows antiradical-scavenging activity
in vitro.27 The complexes formed involving caﬀeic acid-modi-
fied chitosan and a Ru(II) arene are characterised by UV-vis,
FT-IR, circular dichroism (CD), TEM, XRD, and NMR
measurements.
Materials and methods
Materials
Chitosan, caﬀeic acid, 1-ethyl-3(3-dimethylaminopropyl)
carbodiimide hydrochloride (EDC), and N-hydroxysuccinimide
(NHS) were purchased from Sigma-Aldrich. RuCl3·3H2O was
purchased from Precious Metals Online (PMO Pty Ltd). The
p-cymene Ru dimer was prepared as described in the litera-
ture.28 Anhydrous quality of ethanol, tetrahydrofuran and
dichloromethane were used (Aldrich). All other chemicals were
analytical grade, and used as received.
Synthesis
Chitosan (1.0 g) was dissolved at 1% (w/v) in acetic acid
(100 mL), followed by dilution with methanol (80 mL) under
stirring at ambient temperature. The required amount of
caﬀeic acid per sugar residue of chitosan (0.5 mol/mol) was
dissolved in methanol and was added to the chitosan solution.
Then equal amounts (1.5 mol equiv./[caﬀeic acid]) of EDC and
NHS were added into the polymer solution, which allowed the
formation of amide linkages by the reaction with primary
amino groups in chitosan. The resulting reaction mixture was
stirred for 24 hours at ambient temperature, dialysed for
3 days against excess water/methanol mixture (v/v 1/4), and lyo-
philised to obtain a white powder of caﬀeic acid-modified
chitosan.29 For Ru loading, 100 mg of the template-free
mesoporous polymer was dispersed in 20 mL of H2O in a
round-bottom flask. To this was added 20 mg (or 50 mg)
dichlorido(p-cymene)ruthenium dimer (ruthenium dimer)
dispersed in CH3OH (20 mL), then the mixture was stirred vig-
orously for 24 h. The resulting solution was dialysed for 3 days
against an excess amount of water/methanol (4/1 v/v) to obtain
caﬀeic acid-modified chitosan–ruthenium nanoparticles.
Characterisation methods
UV-vis and UV-vis-near IR spectra were recorded on Cary 400
UV-vis and PE Lambda 950 spectrophotometers, respectively.
FT-IR spectra were obtained on a Nicolet 6700 spectrometer
(Thermo Company). X-ray diﬀraction (XRD) patterns were
obtained on a D8ADVANCE (Bruker) diﬀractometer with Cu Kα
radiation (λ = 0.154 nm). CD spectra were recorded with a
Jasco J-810 spectropolarimeter, using a quartz cell with a path
length of 1 cm. 1H NMR spectra of samples were recorded on a
Bruker ARX 400 spectrometer using deuterated solvents.
Chemical shifts are reported as δ in parts per million using
the residual protiated solvent as internal standard. The
polymer sample was dissolved in a CD3COOD/D2O (1% v/v)
solution to a concentration of 20 mg mL−1. Caﬀeic acid
(5 mM) was dissolved in CD3OD. Transmission electron
microscopy images were obtained using a JEOL 2000FX micro-
scope operating at 200 keV. The samples were prepared at
ambient temperature by placing a drop (5 μL) on a Quantifoil
R2/2 TEM grid. The hydrodynamic diameter of nanoparticles
was determined by dynamic light scattering (DLS) using a
Malvern Zetasizer NanoS instrument operating at 25 °C with a
4 mW He–Ne 633 nm laser module. Measurements were made
at a detection angle of 173° (back scattering) and the data were
analysed using Malvern DTS 6.20 software. The hydrodynamic
radius was calculated from the Stokes–Einstein equation
where particles are assumed to be spherical.
Results and discussion
The synthesis of nanostructured materials made of ruthenium
arene complexes with biocompatible and biodegradable chito-
san macro-ligands followed a two-step process (Scheme 1).
Caﬀeic acid-modified chitosan was first synthesised via amida-
tion reactions, before being reacted with the para-cymene
ruthenium dimer [(η6-p-cym)Ru(µ-Cl)Cl]2, to give the metal-
lated particles made of biodegradable, natural polymers
(Scheme 1).
Caﬀeic acid-modified chitosan
Synthesis. Caﬀeic acid and chitosan were reacted with EDC
and NHS in a methanol solution to form amide linkages. The
resulting reaction mixture was stirred for 24 hours at ambient
temperature, dialysed for 3 days against excess water/methanol
mixture (v/v 1/4), and lyophilised to obtain a white powder of
caﬀeic acid-modified chitosan.
UV-vis spectroscopy. The UV spectra of chitosan, caﬀeic acid
and chitosan-caﬀeic acid are shown in Fig. 1. Caﬀeic acid-
modified chitosan (blue line) has two main absorption peaks
at 285 and 320 nm, assigned to n–π* transition from –OH to
the aromatic ring and a π–π* transition of the aromatic ring.
The above results indicated that caﬀeic acid has modified the
chitosan units. Based on the absorption spectra, the grafting
ratio of caﬀeic acid on chitosan was found to be 5.7% [caﬀeic
acid in sample (mg)/sample (mg)].
1H NMR spectroscopy. 1H NMR spectra of chitosan, caﬀeic
acid, chitosan-caﬀeic acid are shown in Fig. 2. Chitosan has a
resonance at 2.0 ppm corresponding to the methyl protons of
the acetylated glucosamine residues, peaks between 3.3 and
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4.5 ppm assignable to the protons of C-3, C-4, C-5, and C-6 of
the pyranose ring, and peaks at 3.1 and 4.8 ppm
corresponding to C-2 and C-5 protons of the glucosamine
residues.30 In the case of the caﬀeic acid-modified chito-
san, new peaks assignable to caﬀeic acid are observed, which
confirms the conjugation of caﬀeic acid to the chitosan
backbone.
FT-IR spectroscopy. The FT-IR spectra of chitosan and chito-
san-caﬀeic acid are illustrated in Fig. 3. The FT-IR spectrum of
chitosan shows large and intense bands at 3366 cm−1 corres-
ponding to the hydrogen-bonded O–H stretches overlapped
with several N–H stretching bands.31 The characteristic absorp-
tion bands at 1657, 1561 and 1317 cm−1 are assignable to
CvO stretching (amide I), N–H bending (amide II) and C–N
stretching (amide III) modes of the residual N-acetyl
groups, respectively.32 Chitosan-caﬀeic acid showed decreases
in intensity of bands associated with protonated glucosamine
residues of chitosan at 1420 and 1457 cm−1, indicating a loss
of –NH3
+ groups and formation of covalent links between the
phenol groups of caﬀeic acid and the amino groups of
chitosan.33,34
Scheme 1 Synthetic route for caﬀeic acid-modiﬁed chitosan–ruthenium nanoparticles.
Fig. 1 UV spectra of chitosan (0.2 mg mL−1), caﬀeic acid (20 µM), chito-
san-caﬀeic acid (0.2 mg mL−1) in 18 mΩ cm water, T = 298 K.
Fig. 2 1H NMR spectra of (A) chitosan in 1% CD3COOD in D2O, (B)
caﬀeic acid in CD3OD, and (C) chitosan-caﬀeic acid in D2O.
Research Article Inorganic Chemistry Frontiers
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Ruthenium-caﬀeic acid modified chitosan complex
Synthesis. Caﬀeic acid-modified chitosan–ruthenium nano-
particles were synthesised by reaction of dichlorido(p-cymene)
ruthenium dimer with a H2O solution of template-free meso-
porous polymer in a weight ratio 1 : 2 (or 1 : 5), followed by
3 days dialysis against an excess amount of water/methanol
(Scheme 1 and Materials and methods).
UV-vis spectrometry. The UV-vis spectra of Ru dimer, caﬀeic
acid-modified chitosan and Ru–caﬀeic acid-modified chitosan
are presented in Fig. 4.
The absorption bands of the Ru–caﬀeic acid-modified
chitosan compound (blue line) at ca. 885 nm can be assigned
to ligand-to-Ru(II) charge transfer.35 The intensity of the two
main bands at ca. 285 and 312 nm decreased remarkably after
ligation of ruthenium to the caﬀeic acid catechol group. These
confirm the formation of a complex between ruthenium and
caﬀeic acid-modified chitosan via the binding of the Ru(II)
centre and the two oxygen atoms from the catechol unit. Fig. 5
shows the kinetic profile of the reaction between the caﬀeic
acid-modified chitosan and the ruthenium dimer by UV-
visible spectroscopy. A bathochromic shift of the absorption
band from ca. 312 nm to ca. 319 nm is observed after addition
of the ruthenium dimer. The shift increases with time up to a
value of ca. 331 nm after 1 h. This confirms the formation
of the complex between the ruthenium and the caﬀeic acid-
modified chitosan. Moreover, such a value is obtained after a
few minutes, which indicates that the reaction progresses
quickly.
Fig. 6 shows UV-vis spectra for the reaction of the Ru dimer
with caﬀeic acid-modified chitosan at diﬀerent initial concen-
trations of Ru dimer. The UV-vis absorption bands at ca. 285 nm
and 312 nm decreased with increasing concentration of the Ru
dimer and isosbestic points are observed at 267 and 325 nm.
When the value of [Ru]/[caﬀeic acid] reaches 1, the intensity of
the absorption bands reaches a maximum value. These results
indicate that a 1 : 1 complex is formed between [(p-cymene)
RuCl]−1 and caﬀeic acid on chitosan and that interactions occur
between ruthenium and caﬀeic acid on the chitosan.
Dynamic light scattering studies. Dynamic light scattering
was used to determine the size of the particles of Ru–caﬀeic
Fig. 3 FT-IR spectra of chitosan and chitosan-caﬀeic acid.
Fig. 4 The UV-vis spectra of Ru dimer (a), caﬀeic acid-modiﬁed chito-
san (b) and Ru–caﬀeic acid-modiﬁed chitosan (c), [Ru dimer] = 1.5 ×
10−4 mol L−1, [caﬀeic acid-chitosan] = 0.4 mg mL−1, in water.
Fig. 5 The UV-vis spectra for the reaction of Ru dimer with caﬀeic
acid-modiﬁed chitosan at diﬀerent reaction times, [Ru dimer] = 2.0 ×
10−5 mol L−1, [caﬀeic acid in caﬀeic acid-modiﬁed chitosan] = 4.0 × 10−5
mol L−1, in water.
Inorganic Chemistry Frontiers Research Article
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acid-modified chitosan. Fig. 7 shows that the hydrodynamic
diameter for the Ru–caﬀeic acid-modified chitosan with
diﬀerent ratios of [caﬀeic acid]/[Ru dimer] ranges from 30 to
120 nm. Interestingly, only one population of particles is
found per loading degree, suggesting that the interactions
between the ruthenium ions and the polymer backbone are
controllable in terms of the architectures obtained.
Transmission electron microscopy. Dry-state TEM samples
were prepared after dialysis of the particles for 4 days but a
drying eﬀect was observed which led to a spreading of the
chitosan nanoparticles (see Fig. S1†). No information regarding
the size of the particles can thus be retrieved from the dry-
state TEM. However, the noticeable diﬀerence in contrast
between the metallic parts of the particles (shown by arrows in
Fig. S1†) and the organic parts of the polymer chains, shows
that the ruthenium ions did not dissociate from the caﬀeic
acid-modified chitosan after dialysis, suggesting a relatively
strong bonding between the metal and its ligands (in accord-
ance with the proposed chelated structure).
Powder X-ray diﬀractometry of Ru–caﬀeic acid-modified chito-
san. The X-ray diﬀractograms of chitosan, caﬀeic acid-modi-
fied chitosan, and Ru–caﬀeic acid-modified chitosan are
presented in Fig. 8. It was observed that the diﬀractogram of
chitosan consisted of two major peaks at ca. 10.0° and 20.1°.
Compared with chitosan, the diﬀractogram of caﬀeic acid-
modified chitosan exhibited some changes in peak intensity
and peak width. The peak at 10.0° disappeared, while the peak
intensity at around 20.1° decreased and the peak width
increased. Such a weaker and broader peak indicated a more
amorphous phase of the caﬀeic acid-modified chitosan matrix.
In addition, the peak at ca. 20.1° of Ru–caﬀeic acid-modified
chitosan disappeared, implying that the Ru–caﬀeic acid-modi-
fied chitosan was considerably more amorphous than chitosan
and caﬀeic acid-modified chitosan. The structure of chitosan
was greatly perturbed by anchoring ruthenium complexes to
its backbone.
CD spectroscopy of Ru–caﬀeic acid modified chitosan. The
circular dichroism spectra of caﬀeic acid-modified chitosan
solution in the absence and presence of Ru dimer are shown
in Fig. 9. The CD spectrum of caﬀeic acid-modified chitosan
Fig. 6 Top: UV-vis spectra for the reaction of various concentrations of
Ru dimer with caﬀeic acid-modiﬁed chitosan, [caﬀeic acid in caﬀeic
acid-modiﬁed chitosan] = 5.0 × 10−5 mol L−1, in water. Bottom: Changes
in absorbance at 312 nm at various concentrations of Ru dimer with
caﬀeic acid-modiﬁed chitosan.
Fig. 7 Dynamic light scattering of Ru–caﬀeic acid modiﬁed chitosan at
two diﬀerent ratios. Spectra were recorded at 25 °C; 2 mg mL−1; the
solutions were not ﬁltered before analysis.
Fig. 8 XRD of chitosan, caﬀeic acid-modiﬁed chitosan, and Ru–caﬀeic
acid-modiﬁed chitosan.
Research Article Inorganic Chemistry Frontiers
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in the absence of Ru dimer exhibits a strong negative
CD band at ca. 210 nm, which corresponds to n → π* elec-
tronic transitions of the –NH–CO– chromophore of
GlcNAc units. The Ru dimer did not show circular dichroism
bands at 210 nm. As shown in Fig. 9, the intensity of the
main CD band of caﬀeic acid-modified chitosan is higher
than that of the caﬀeic acid-chitosan modified by interacting
with the Ru dimer, which suggests that Ru binding induces a
change of molecular forces, symmetry, and backbone struc-
ture of chitosan. In addition, the CD band at about 285 nm
shifted to 270 nm, which indicates the formation of a
complex between ruthenium and caﬀeic acid-modified
chitosan.
Conclusions
Nanoparticles of chitosan bearing anchored ruthenium com-
plexes ca. 20 nm in size were prepared and studied by UV-
vis, FT-IR, NMR, DLS, TEM, XRD, and CD analysis. The multi-
spectral results reveal that strong interactions are present
between ruthenium and the oxygen atoms of the catechol unit
on caﬀeic acid. The analysis of the particles in aqueous solu-
tion by dynamic light scattering revealed the nanometric size
of the Ru–caﬀeic acid-modified chitosan nanoparticles. In
addition, reaction with the Ru dimer appears to induce a
change of molecular forces, symmetry, and backbone structure
of chitosan. These results suggest that the Ru–caﬀeic acid
modified chitosan nanoparticles have potential for investi-
gation as alternative polymer–based metal anticancer drugs.
Furthermore, (O,O)-chelated ligands in anticancer complexes
of the type [Ru(η6-arene)(O,O-chelate)Cl]n+ have been shown
not only to be labile in solution (formation of the hydroxo-
bridged dimer [((η6-arene)Ru)2(μ-OH)3]+),36 but also to increase
the rate and extent of hydrolysis,37 suggesting that the ruthe-
nium unit should readily be released from the chitosan
nanoparticles.
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